This was a monumental shift because most disease nonprofits had traditionally focused their fundraising dollars on academic and medical research. The Cystic Fibrosis Foundation, a 501 (c) (3) nonprofit organization, has unrestricted financial reserves of about 14 times its 2022 operating budget. The Cystic Fibrosis Foundation is the world's leader in the search for a cure for CF and supports a broad range of research initiatives to tackle the disease from all angles. For decades, we have been taking major steps and pioneering new ways to find a cure for cystic fibrosis. Exits 14. Find out more about how you canapply for the programme. Find out how your donations are making a difference. Cystic Fibrosis Foundation 22,541 followers 6d We have invested up to an additional $4.85 million in Aridis Pharmaceuticals to complete a Phase 2a clinical trial for a non-traditional. "The CF Foundation has a long track record of success in facilitating the development of new cystic fibrosis therapies. Bethesda, Maryland 20814. Cystic Fibrosis Foundation (national office) The Intern assists in implementing operational best practices to support the total investment program, executing the investment strategy, and researching new investment opportunities. The Associate participates in formulating the investment strategy, underwriting, and investing into new opportunities, and managing the total investment portfolio. We reach beyond boundaries in pursuit of our vision. SalioGens Gene Coding, controlled manner to maintain the normal, regulated expression of genes such as cystic fibrosis transmembrane conductance regulator (CFTR). Nearly every CF medicine available today was made possible because of Foundation support. It requires an ambitious research agenda to accelerate treatments and drug development for the underlying cause of the disease, and ultimately deliver a cure. View More Jobs at Cystic Fibrosis Foundation, Investments intern in Cystic Fibrosis Foundation. ET, 5 p.m. PT. The CF Foundation is an equal opportunity employer that is committed to being an employer of choice, not just a good place to work, but a great and inclusive place to work. Assist with note taking during existing and prospective manager meetings, and upkeep of Investment Team databases. CB Rank (Hub) 50,874. The inhaled mRNA-based therapeutic is intended for people with CF, including those with genotypes that are not responsive to approved CFTR modulators. The Investments Intern supports the Investments Team with the oversight and management of the Cystic Fibrosis Foundation's $5 billion investment portfolio. The above is intended to describe the general content of and requirements for the is not to be construed as an exhaustive statement of essential functions, responsibilities or requirements. `` We 're excited to work with the Cystic Fibrosis Foundation , the world 's leader in supporting breakthrough technologies for cystic fibrosis , '' said Geoffrey von Maltzahn , Ph.D , Co-Founder and CEO of Tessera Therapeutics , and General Partner at Flagship Pioneering . Today, the Foundation is investing more aggressively than ever before to support development of the next generation of transformative therapies to help people with CF live their longest, healthiest lives possible. We support one another. Suite 1100 N The Cystic Fibrosis Foundation offers competitive compensation (base pay and incentive), benefits, and professional development opportunities that maximize our ability to recruit, retain, reward, and motivate a highly-qualified and diverse workforce. If you are a member of a news or media organization and need assistance, please contact the CF Foundations media team at mediarelations@cff.org. To subscribe, select any of the newsletters listed below. Visit the Career Advice Hub to see tips on interviewing and resume writing. Consultant/Licensed Site Remediation Professional (LSRP), Mortgage Production | Mortgage Career Exchange, Taguig, National Capital Region, Philippines, Social Media Coordinator & Content Creator, Autocad Drafter Designer (OSP - Fiber/coax), Santa Cruz de la Sierra, Santa Cruz, Bolivia, Resource Planner - Recruiter onsite met bedrijfswagen en tankkaart (Zaventem), Mortgage Underwriter | Mortgage Career Exchange, See who Cystic Fibrosis Foundation has hired for this role, PINKERTON | Comprehensive Risk Management. Established in 1955, the purpose of this foundation is to cure cystic fibrosis and to provide all people the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment, and ensuring access to high-quality, specialized care. Capacity to conduct thorough investment analysis, including appropriate modeling and identifying merits, and risks of investment opportunities. A) Salary.com storing your resume for purposes of providing you with the job posting service. In 1989, a team of scientists supported by the Foundation discovered the cystic fibrosis gene and opened the door to our understanding of the disease at its most basic level. Overview of Cystic Fibrosis . We are a nonprofit, donor-supported organization that has raised and invested billions of dollars to help develop cystic fibrosis therapies that have changed the lives of people with this disease. Your job seeking activity is only visible to you. Experience building a sourcing network for new investment opportunities. A person will be born with CF only if 2 CF genes are inheritedone . Click the link in the email we sent to to verify your email address and activate your job alert. People with CF have mucus that is too thick and sticky, which. POSITION SUMMARY Research investment strategies, sector verticals, geographic markets, and other areas that offer potential investment opportunities and provide findings to the Investment Team. Bakar Labs to award lab space to startups developing gene tech for cystic fibrosis. This, in turn, affects glands that produce mucus, tears, sweat, saliva and digestive juices. See the metrics below for more information. Win whats next. Bachelors degree required, masters degree or CFA designation beneficial. Funding calls from other funders of CF research View the job description, responsibilities and qualifications for this position. Hazard Analysis and Critical Control Points (HACCP) Skill, Summer 2023 Intern, Asset Services and Capital Investments Rotational Intern, Washington DC, Cushman & Wakefield U.S., Inc., Washington, DC. Cystic Fibrosis Foundation has 5 team members, including former President, Andrew L. Beja. Established in 1955, the purpose of this foundation is to cure cystic fibrosis and to provide all people the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment, and ensuring access to high-quality, specialized care. The Foundation is currently funding many different genetic therapy programs. POSITION SUMMARY Cystic Fibrosis Foundation. Cystic Fibrosis Foundation has made 53 investments. Introduction to multiple investment asset classes. --The Cystic Fibrosis Foundation announced today that it has invested in SalioGen Therapeutics to support the companys preclinical research into a novel genetic therapy for cystic fibrosis. The Internship is centered around learning, development, and collaboration with the Investments Team. Nearly every CF medicine available today was made possible because of Foundation support. Apr 2014 - Apr 20173 years 1 month. LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads) on and off LinkedIn. Get in touch with us to speak to someone on our Helpline, find out about an event or speak to our press team. Today, we invest more than $225 million per year in CF research and care. Learn more. Take a look at our current opportunities and find out how to apply. (415) 353-2961. (1-800-344-4823) By continuing to use this site you are consenting to these choices. We're committed to funding research and supporting researchers at all stages of their career. Exposure to investment opportunities in a wide variety of sectors and geographies. We are a nonprofit, donor-supported organization that has raised and invested billions of dollars to help develop cystic fibrosis therapies that have changed the lives of people with this disease. The Internship is centered around . JOB DUTIES AND RESPONSIBILITIES: Contribute to investment manager diligence and monitoring efforts through project-based work. We invite you to explore opportunities to get involved and to get support. Their most recent diversity investment was on Jan 10, 2023, when ReCode Therapeutics raised $10M. The Foundation funds more CF research than any other organization, and nearly every CF drug available today was made possible because of Foundation support. This progress has added decades of life and hope for people with CF, but critical work remains to ensure that every person has an effective therapy to address their underlying cause of disease. Cystic Fibrosis Foundation (national office) 4550 Montgomery Ave. Suite 1100 N Bethesda, MD 20814 Local: 301-951-4422 Toll free: 800-FIGHT-CF(800-344-4823) Email:info@cff.org(see the Chapter Directoryfor local e-mail addresses) Important: Please include your full mailing address and phone number in all electronic correspondence. Ability to communicate effectively and foster deep relationships. Bethesda, MD 20814, Journal of CF Highlights Cost Burden Prevalent in the Cystic Fibrosis Community, CF Foundation Applauds Reintroduction of the HELP Copays Act, CF Foundation Formalizes Recommendations to Address Health Inequities, CF Foundation Reflects on Progress Toward Equity, Racial Justice, Diversity, and Inclusion, CF Foundation Invests Up to $15M in ReCode Therapeutics for Development of mRNA Therapy, CF Foundation Invests Up to $3.5M in Gensaic for Novel Gene Delivery Method, CF Foundation Urges Vertex Pharmaceuticals to Reverse Consequential Decision on Copay Assistance, Newly Expanded Cystic Fibrosis Foundation Lab Will Enable More Research Into Genetic Therapies, What I Didnt Expect About Transitioning From Pediatric to Adult CF Care, Adapting to Life as a Parent of a Child With CF, Having Tough Conversations With My Kids About My CF, It Turns Out I Wasnt Clumsy, I Have Vestibular Loss, How Family Relationships Have Grown Along With Day-to-Day Life. Gene therapy involves inserting a new version of the CFTR DNA into the cells of people with cystic fibrosis. We know it can feel hard to know where to start, so we've collected a few key items to help you. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. Working toward a four-year college degree (Rising seniors strongly preferred), Ability to work collaboratively with team members to accomplish objectives. Keep sight of what really matters: Our decisions are based on what is best for people with cystic fibrosis and their families. By creating this job alert, you agree to the LinkedIn User Agreement and Privacy Policy. Position Description The Cystic Fibrosis Foundation (CF Foundation) and its employees embrace their commitment to its core values. Chapter Office Location . The foundation turned this steady flow into a waterfall: It sold its royalties in Kalydeco and other future Vertex cystic fibrosis products in 2014 to Royalty Pharma (Nasdaq: RPRX) for $3.3. The Bethesda, Maryland-based foundation had more than $3.65 billion in investment assets as of December 31, 2014, according to regulatory filings. KNOWLEDGE, SKILLS AND ABILITIES REQUIRED: Working toward a four-year college degree (Rising seniors strongly preferred) Ability to work collaboratively with team members to accomplish objectives Ability to prepare well-written, organized material and present recommendations in a clear and concise manner. And in 2020, we successfully completed a sale of our remaining stake in royalties related to Vertexs therapies for an upfront payment of $575 million and a potential future payment of $75 million, bringing additional resources to the fight against CF. Candid gets you the information you need to do good. ReCode Therapeutics CEO Shehnaaz Suliman said: Youre viewing 5 of 22 team members. These core values are the pillars on which the CF Foundation stand and will continue to sustain us as we move forward. This beacon provides an assessment of a charity's financial health (financial efficiency, sustainability, and trustworthiness) and its commitment to governance practices and policies. Celebrate progress made in 2022 with members of the CF community and our President and CEO, Michael Boyle, MD, who will share his vision for the year ahead during our National Annual Meeting, Thursday, January 26 at 8 p.m. You can update your choices at any time in your settings. Preparing and presenting investment analyses and recommendations to internal team and Investment Committee of the Board. ReCode's CFTR mRNA therapy aims to compensate for mutated CFTR . The Trust aims to create abalanced portfolio of research programmes, with both early stage programmes and those addressing later stage clinical programmes. Suite 1100 N OurVenture and Innovation Awards(VIAs) provide financial support to innovative research projects and allow the Trust to bring in funding from external agencies. Journal of CF Highlights Cost Burden Prevalent in the Cystic Fibrosis Community, CF Foundation Formalizes Recommendations to Address Health Inequities, CF Foundation Reflects on Progress Toward Equity, Racial Justice, Diversity, and Inclusion, Cystic Fibrosis Foundation Announces Investment in SalioGen Therapeutics to Fund Genetic Therapies Research, BETHESDA, Md. Sourcing new opportunities and investment partners across the globe and all asset classes (public markets, private markets, and opportunistic). SalioGen hopes that by inserting a large piece of the healthy CFTR DNA and enabling the expression of functional CFTR protein in the lungs of. Get email updates for new Investment Intern jobs in Bethesda, MD. It causes changes in the electrolyte transport system which causes cells to absorb too much sodium and water. Contribute to investment manager diligence and monitoring efforts through. The Foundation continues to evolve our venture philanthropy approach to take advantage of emerging science with the potential to benefit individuals with CF who are most in need of new therapeutic options. Contact a dedicated CF Foundation Compass case manager: The Cystic Fibrosis Foundation is a leading healthcare nonprofit organization like no other. 2023 PitchBook. For medical advice, talk to your CF care team or other health care provider to answer any questions you may have. Find out about ourfunding process and governance. They fund more CF research than any other organization in the world, and nearly every CF drug available today was made possible because of our support. Cystic Fibrosis Foundation has 10 strategic partners and customers. C) Salary.com using cookies (as described here) to refine and tailor the website visitor experience. The Cystic Fibrosis Foundation has committed $20 million to support the development of innovative therapeutics and early-stage companies focusing on cystic fibrosis (CF). Our comprehensive benefits package includes medical, dental, and vision coverage; generous time-off and leave policies; a holistic well-being program; health savings and flexible spending accounts; employer-provided life and disability insurance; retirement savings benefits; and a variety of work-life benefits to support employees and their family members. Help support Cystic Fibrosis Foundation today! Nearly every CF medicine available today was made possible because of Foundation support. Select A Team: About CFF Cares; Find an Event . For decades, we have been t Do you want to receive a free, professional resume evaluation from TopResume? The Cystic Fibrosis Foundation is a leading healthcare nonprofit organization like no other. We are the global leader in the search for a cure for cystic fibrosis and nearly every CF drug and therapy available today was made possible because of CF Foundation support. Introduction to multiple investment asset classes. please try again later. The Cystic Fibrosis Foundation is the world's leader in the search for a cure for Cystic Fibrosis, a life-threatening genetic disease that affects more than 30,000 people in the united states, and 70,000 worldwide.the Foundation accomplishes its mission by funding life-saving research to discover and develop effective therapies for people with cf. 1. We listen with respect. Join to apply for the Investments Associate role at Cystic Fibrosis Foundation. Amount: $5,000. This rating has decreased by -8% over the last 12 months. Cystic Fibrosis Foundation has made 31 investments. B) Salary.com being able to use your name and address to tailor job posting to your geographic area. SalioGens Gene Coding approach seeks to insert a large piece of healthy CFTR DNA at a precise location within the CFTR gene, which could enable the expression of a functional CFTR protein in essentially all individuals with CF, regardless of their individual mutation.. With a growing sense of impatience, Robert J. Beall, PhD, then president and CEO of the Foundation, landed on an idea called venture philanthropy to break through the pharmaceutical industrys reluctance to get involved in cystic fibrosis research. Ability to communicate effectively and foster deep relationships. Vertex developed the drug with the help of a $75 million investment from the Cystic Fibrosis Foundation -- as well as a hefty investment from taxpayers through grants from the National. Highly skilled surgeons perform lung transplant surgery. Since many of our patients were diagnosed with cystic fibrosis as children or teenagers, we . We'll be sending you new jobs as they are posted. Preference prior experience conducting investment due diligence on direct investments, co-investments, and investment funds. Learn more in our Cookie Policy. Fri, 9 am - 3 pm ET, High-Frequency Chest Wall Oscillation (the Vest). The Cystic Fibrosis Foundation is the world's leader in the search for a cure. Join us and you will join an amazing team, devoted to our community, and our mission. The CF Foundation is the world's leader in the fight against CF, and our scientific portfolio reflects our drive to provide effective treatments and one day a cure to every individual with this disease. Fundamentals of asset allocation and portfolio management. The Foundation continues to evolve its venture philanthropy approach to take advantage of emerging science with the potential to benefit individuals with CF who are most in need of new therapeutic options. Find out about our funding process and governance. Margot Cleveland bought steaks. Ability to prepare well-written, well-organized material, and present recommendations in a clear and concise manner. Find out more aboutapplying for this stream of funding. Their latest portfolio exit was Aceragen on September 28, 2022. Through our venture philanthropy model, we provide early stage funding to companies to develop breakthrough drugs for adults and children with cystic fibrosis. Cystic Fibrosis Foundation. BETHESDA, MD 20814-3304 | Tax-exempt since Nov. 1957. We listen with respect. Join to apply for the Investments Intern role at Cystic Fibrosis Foundation. Reports to Managing Director, Investments; no direct reports. With the steadfast support of the CF community and unprecedented momentum in research powered by our venture philanthropy model, we have more hope for the future than ever before. ReCode Therapeutics has announced that it will secure a strategic investment from the Cystic Fibrosis Foundation (CF Foundation) to develop its inhaled mRNA-based therapeutic for cystic fibrosis (CF). Tessera Therapeutics Announces R&D Collaboration with Cystic Fibrosis Foundation as Part of a Portfolio of Complementary Technologies Advanced by Flagships Pioneering Medicines to Treat Cystic Fibrosis. Percentage of Public Organizations 26%. By clicking Agree & Join, you agree to the LinkedIn, You can save your resume and apply to jobs in minutes on LinkedIn. People with CF and their loved ones were hopeful that this discovery would quickly lead to new drugs to fight this rare and fatal disease. Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights platform. This is a profile preview from the PitchBook Platform. We are a nonprofit, donor-supported organization that has raised and invested billions of dollars to help develop cystic fibrosis therapies that have changed the lives of people with this. Our goal is a cure for 100% of people living with CF and we refuse to leave anyone behind. With SalioGens approach, the goal is to edit and correct the existing CFTR gene by inserting new CFTR DNA at a precise location within the faulty native gene in order to restore normal expression of CFTR protein. CYSTIC FIBROSIS FOUNDATION. Cystic Fibrosis Foundation is searching for a cure for people with cystic fibrosis, a genetic disease that progressively limits the ability to breathe, causing debilitating lung infections, and ultimately, premature death. The proceeds of the sale will dramatically accelerate and expand the foundations research, care, and patient programs and significantly boost its funding of research targeting the genetic cause of CF. machinery utilizes a proprietary mammalian enzyme that is designed to allow the integration of DNA sequences without causing double-strand DNA breaks and potential unwanted DNA damage. To ensure that potential treatments can advance swiftly through development so that they are made available to . Understanding Genetic Therapies and Their Potential to Cure CF, The Foundations investment in SalioGen is part of our $500 million, The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. For more information, visit cff.org. Stronger together: We collaborate and work together so that we can learn more and achieve more. BETHESDA, Md., January 05, 2022--The Cystic Fibrosis Foundation announced today that it has invested in SalioGen Therapeutics to support the company's preclinical research into a novel genetic . Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals Funds to be used to further advance development of lead candidate AP-PA02, which is being evaluated in a Phase 1b/2a. We have set up ourStrategic Research Centres(SRCs) to exploit the latest opportunities in science, encourage internationally-competitive researchers to lend their talents to cystic fibrosis (CF) research, facilitate new partnerships, widen awareness of CF research and recruit the brightest and best young researchers. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. By agreeing to submit your resume, you consent (in accordance with our Terms of Use and Privacy Policy) to: Should you have any questions or wish have your information removed from our service, please contact us here. We fund research to tackle some of the most pressing issues in CF today. Innovate with courage: We embrace challenges. Number of Founders 59. Cystic Fibrosis Foundation (CF Foundation) is an independent non-profit foundation based in Bethesda, Maryland. When expanded it provides a list of search options that will switch the search inputs to match the current selection. Get notified about new Investment Associate jobs in Bethesda, MD. Research salary, company info, career paths, and top skills for Investments intern You can read more about your cookie choices at our privacy policyhere. If you need assistance or would like to request an accommodation due to a disability, please contact us at HROps@cff.org. Our bold investments in innovative research sparked the development of . "I would like to see them do more to get the price of this drug down to something that is going to be sustainable," Paul M. Quinton, a CF researcher at the UC San Diego School of Medicine, told the Times. Visit the Career Advice Hub to see tips on interviewing and resume writing. The Cystic Fibrosis Foundation, headquartered in Bethesda, MD., is a donor-supported, nonprofit organization committed to finding therapies and ultimately a cure for CF, and to improving the lives of those with the disease. In the years that followed, our venture philanthropy model later supported the development of additional therapies, lumacaftor/ivacaftor (Orkambi) and tezacaftor/ivacaftor (Symdeko), that benefited more people with CF, including those with the most common mutations. Cystic fibrosis is a genetic disorder that affects the lungs, pancreas, and other organs. Its machinery is being delivered using a lipid nanoparticle, which could allow potential re-dosing of the therapy with low risk of dangerous immune responses. Capable of integrating complex information and concepts, and synthesizing efforts into a systematic framework. Improving the investment process, including work on investment operations, performance management and risk management. The Cystic Fibrosis Foundation (CFF) is a 501(c)(3) . It became clear in 2012 that our venture strategy was a success. In April 2022, the Foundation announced a $5 million investment to life science treatment company Sionna Therapeutics, for the development of a new cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a type of therapy that treats the underlying cause of CF. CFTR modulator therapies have changed the lives of many people with CF, but not everyone can benefit. People with CF are living longer, healthier lives than ever before. CF Foundation Awards Contract to Life Edit Therapeutics to Explore Gene Editing Technology in CF. Minimum of 3 years of investments work-related experience. Instagram; Facebook; Twitter; Tweets. This approach has super-charged the field of CF by helping to de-risk and accelerate the development of new technologies in CF, resulting in more than 16 approved therapies -- including medicines that treat the underlying cause of CF for many people with the disease. Copyright 2023 CB Information Services, Inc. All rights reserved. For more information, visit, Cystic Fibrosis Foundation Invests $6M in Carbon Biosciences to Advance New Gene Therapy Approach for Cystic Fibrosis, Cystic Fibrosis Foundation Strikes First-of-Its-Kind Deal With Pioneering Medicines, a Flagship Pioneering Initiative, CF Foundation Funds Three New Research Awards to Advance its Path to a Cure Initiative. Applications from post-doctoral researchers at any stage in their careers are encouraged. In 2000, the Foundation made its first large investment: $40 million with Aurora Biosciences (now Vertex Pharmaceuticals) to discover compounds that might correct the core genetic defect in people with CF. Cleveland's son, 10, was born with cystic . How: Learn more about the scholarship criteria and how to apply. We strive to recruit and maintain a diverse workforce. Reasonable Accommodations: The CF Foundation is committed to providing reasonable accommodations for qualified individuals with disabilities in our job application procedures. SalioGens Gene Coding approach aims to modify an individuals DNA in a highly controlled manner to maintain the normal, regulated expression of genes such as cystic fibrosis transmembrane conductance regulator (CFTR). BETHESDA, Md. Sign in to save Investments Associate at Cystic Fibrosis Foundation. We are committed to continuous learning and improvement. Assist with note taking during existing and prospective manager meetings, and upkeep of Investment Team databases. CF is characterized by problems in the glands that produce sweat and mucus. blocks airways and leads to lung damage; traps germs and makes infections more likely; and. The 40 Under 40 Outstanding Young Professionals of South Florida is a campaign recognizing 40 outstanding professionals from South Florida under the age of 40. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. The Foundation continues to evolve our venture philanthropy approach to take advantage of emerging science with the potential to benefit individuals with CF who are most in need of new therapeuticoptions. Washington DC-Baltimore Area . Most fairs are hosted by academic departments and colleges to serve their students and related industries. In 2015, the UK Cystic Fibrosis Gene Therapy Consortium took a liposome-based treatment as far as a phase IIb trial 7, but it only improved lung function by a few percentage points and never . We are committed to continuous learning and improvement. Care about our people: We deeply care about each other and all who support our shared mission. They note, for example, that Kalydeco costs $300,000 a year and argue that CFF should be doing more to bring down its cost. These reserves are largely a result of the Foundation's successful venture philanthropy model, through which we have raised and invested hundreds of millions of dollars to help discover and . Cystic Fibrosis Foundation has had 14 exits. Venture philanthropy, where a nonprofit organization provides funding to a for-profit company to de-risk an investment, was an entirely new approach to funding research. Ability and interest in researching and uncovering new insights. The Cystic Fibrosis Foundation is the world's leader in the search for a cure for people with cystic fibrosis, a rare, genetic disease that progressively limits the ability to breathe, causing debilitating lung infections, and ultimately, premature death. Investments 53. Contacts 718. CF affects about 35,000 people in the United States. Los Gatos, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company today announced the Cystic Fibrosis Foundation invested $4.85 million .
Friendly Womack Jr,
Plattsburgh State Hockey Tickets,
Tunbridge Wells Hospital Covid,
Articles C